BMY

Cancer treatment pricy but spending is moderating

moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]

Bristol-Myers Squibb Continues to Lead the Advancement of Immuno-Oncology with Broad Set of New Data at 2014 American Society of Clinical Oncology (ASCO) Annual Meeting

[Business Wire] – Bristol-Myers Squibb Company today announced that new data from studies investigating its immunotherapies in adjuvant and advanced melanoma, non-small cell lung cancer and metastatic renal cell carcinoma will be presented at the 50th An moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click […]

BRISTOL MYERS SQUIBB CO Financials

moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]

What You Need to Know About New Hepatitis C Drugs

moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]

[video] Big pharma targets and takeovers

moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]

Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement

[Business Wire] – NEW YORK & SEOUL, South Korea–(BUSINESSWIRE)– Bristol-Myers Squibb Company (NYSE:BMY) and Samsung BioLogics today announced the companies will increase the scope of their existing manufacturing agreement … moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]

7:01 am Bristol-Myers presents Phase III data demonstrating that investigational all-oral daclatasvir and asunaprevir therapy achieved SVR12 rates of up to 90% among broad range of genotype 1b hepatitis C patients

moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]